Wells Fargo Upgrades Celldex Therapeutics (CLDX) to Equal Weight
Tweet
Share
E-mailGet Alerts CLDX Hot Sheet
Price: $38.53 -1.48%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 53
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 53
Join SI Premium – FREE
Wells Fargo analyst Derek Archila upgraded Celldex Therapeutics (NASDAQ: CLDX) from Underweight to Equal Weight with a price target of $27.00.
For an analyst ratings summary and ratings history on Celldex Therapeutics click here. For more ratings news on Celldex Therapeutics click here.
Shares of Celldex Therapeutics closed at $25.78 yesterday.
You May Also Be Interested In
- BofA Securities Upgrades Saia Inc. (SAIA) to Buy
- Wells Fargo Double Upgrades Pembina Pipeline Corp. (PPL:CN) (PBA) to Overweight
- Macquarie Upgrades Muangthai Capital PCL (MTC:TB) to Outperform
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
